These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31388630)

  • 1. Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.
    Teratani T; Tomita K; Furuhashi H; Sugihara N; Higashiyama M; Nishikawa M; Irie R; Takajo T; Wada A; Horiuchi K; Inaba K; Hanawa Y; Shibuya N; Okada Y; Kurihara C; Nishii S; Mizoguchi A; Hozumi H; Watanabe C; Komoto S; Nagao S; Yamamoto J; Miura S; Hokari R; Kanai T
    Hepatol Commun; 2019 Aug; 3(8):1098-1112. PubMed ID: 31388630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells.
    Teratani T; Tomita K; Wada A; Sugihara N; Higashiyama M; Inaba K; Horiuchi K; Hanawa Y; Nishii S; Mizoguchi A; Tanemoto R; Ito S; Okada Y; Kurihara C; Akita Y; Narimatsu K; Watanabe C; Komoto S; Oike Y; Miura S; Hokari R; Kanai T
    Hepatol Res; 2021 May; 51(5):580-592. PubMed ID: 33247991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
    Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Okada Y; Kurihara C; Irie R; Yokoyama H; Shimamura K; Usui S; Ebinuma H; Saito H; Watanabe C; Komoto S; Kawaguchi A; Nagao S; Sugiyama K; Hokari R; Kanai T; Miura S; Hibi T
    Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice.
    Kim KE; Lee J; Shin HJ; Jeong EA; Jang HM; Ahn YJ; An HS; Lee JY; Shin MC; Kim SK; Yoo WG; Kim WH; Roh GS
    Hepatology; 2023 Mar; 77(3):888-901. PubMed ID: 35560370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
    Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis.
    Yao Q; Li S; Li X; Wang F; Tu C
    Front Med (Lausanne); 2020; 7():71. PubMed ID: 32195263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic carboxypeptidase-like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis.
    Teratani T; Tomita K; Suzuki T; Furuhashi H; Irie R; Nishikawa M; Yamamoto J; Hibi T; Miura S; Minamino T; Oike Y; Hokari R; Kanai T
    J Clin Invest; 2018 Apr; 128(4):1581-1596. PubMed ID: 29553485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Breuer DA; Pacheco MC; Washington MK; Montgomery SA; Hasty AH; Kennedy AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G211-G224. PubMed ID: 31709830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells.
    Zhang C; Teng Y; Li F; Ho W; Bai X; Xu X; Zhang XQ
    ACS Nano; 2023 Aug; 17(15):14852-14870. PubMed ID: 37490628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation.
    Liu XJ; Xie L; Du K; Liu C; Zhang NP; Gu CJ; Wang Y; Abdelmalek MF; Dong WY; Liu XP; Niu C; Yang C; Diehl AM; Wu J
    Liver Int; 2020 Apr; 40(4):830-843. PubMed ID: 31903720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis.
    Chen H; Zhao W; Yan X; Huang T; Yang A
    J Clin Transl Hepatol; 2022 Aug; 10(4):577-588. PubMed ID: 36062292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
    Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells.
    Han J; Zhang X; Lau JK; Fu K; Lau HC; Xu W; Chu ES; Lan H; Yu J
    J Pathol; 2019 Aug; 248(4):488-500. PubMed ID: 30945293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.
    Allen J; Zhang J; Quickel MD; Kennett M; Patterson AD; Hankey-Giblin PA
    J Proteome Res; 2018 Sep; 17(9):3268-3280. PubMed ID: 30091925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2008 Feb; 47(2):625-35. PubMed ID: 18000880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
    Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T
    Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.